483 Samsung Biologics Jul 2017

483 Samsung Biologics Jul 2017

Zhong Li FDA, Maria Lopez- Barragan FDA$119.00 - Available Now

FDA investigators audited the Samsung Biologics - Yeonsu-gu, Korea (the Republic of) facility and issued inspectional observations (via FDA 483) on 25 Jul 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Jul 2017
  • Location: Yeonsu-gu, Korea (the Republic of)
  • FEI: 3010479596
Add To Cart